Literature DB >> 2584765

Epidemiology and spectrum of Vibrio infections in a Chesapeake Bay community.

C W Hoge1, D Watsky, R N Peeler, J P Libonati, E Israel, J G Morris.   

Abstract

The clinical and epidemiologic features of vibrio infections occurring over 15 y in a hospital adjacent to the Chesapeake Bay were examined. Microbiologic techniques included the use of thiosulfate citrate bile salts sucrose (TCBS) medium on all stool specimens. Among 40 vibrio isolates from 32 patients, eight species were identified: V. parahaemolyticus (16), V. vulnificus (10), non-O1 V. cholerae (7), V. mimicus (3), V. hollisae (1), V. fluvialis (1), V. alginolyticus (1), and an unnamed halophilic vibrio. Sources included stool (13), wound (11), sputum (3), ear (3), bone (1), and gallbladder (1). While illnesses were diverse, they were relatively mild and self-limited with no mortality. The mild clinical spectrum and especially lack of mortality are in sharp contrast to the findings of previous reports. Even with the proximity to the bay and use of optimal isolation techniques, the demonstrated incidence of vibrio infections was low (1.6/100,000/y). The routine use of TCBS medium, which has been advocated for high-risk areas, was not cost-effective.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2584765     DOI: 10.1093/infdis/160.6.985

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Temporal and spatial variability in the distribution of Vibrio vulnificus in the Chesapeake Bay: a hindcast study.

Authors:  Vinita Banakar; Guillaume Constantin de Magny; John Jacobs; Raghu Murtugudde; Anwar Huq; Robert J Wood; Rita R Colwell
Journal:  Ecohealth       Date:  2011-12       Impact factor: 3.184

2.  Necrotizing fasciitis caused by Vibrio vulnificus: first published infection acquired in Turkey is the second time a strain is isolated in Germany.

Authors:  R Horré; S Becker; G Marklein; T Shimada; R Stephan; K Steuer; E Bierhoff; K P Schaal
Journal:  Infection       Date:  1998 Nov-Dec       Impact factor: 3.553

3.  Seasonality of Chesapeake Bay bacterioplankton species.

Authors:  J F Heidelberg; K B Heidelberg; R R Colwell
Journal:  Appl Environ Microbiol       Date:  2002-11       Impact factor: 4.792

4.  Experimental non-O group 1 Vibrio cholerae gastroenteritis in humans.

Authors:  J G Morris; T Takeda; B D Tall; G A Losonsky; S K Bhattacharya; B D Forrest; B A Kay; M Nishibuchi
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

5.  Does Vibrio vulnificus present a health threat to Canadians?

Authors:  S Stavric; B Buchanan
Journal:  Can J Infect Dis       Date:  1997-09

6.  Identification of Vibrio hollisae associated with severe gastroenteritis after consumption of raw oysters.

Authors:  A M Carnahan; J Harding; D Watsky; S Hansman
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

7.  Clinical manifestations and molecular epidemiology of Vibrio vulnificus infections in Denmark.

Authors:  A Dalsgaard; N Frimodt-Møller; B Bruun; L Høi; J L Larsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-03       Impact factor: 3.267

8.  Non-O1/non-O139 Vibrio cholerae carrying multiple virulence factors and V. cholerae O1 in the Chesapeake Bay, Maryland.

Authors:  Daniela Ceccarelli; Arlene Chen; Nur A Hasan; Shah M Rashed; Anwar Huq; Rita R Colwell
Journal:  Appl Environ Microbiol       Date:  2015-01-02       Impact factor: 4.792

9.  Preclinical immunoprophylactic and immunotherapeutic efficacy of antisera to capsular polysaccharide-tetanus toxoid conjugate vaccines of Vibrio vulnificus.

Authors:  S J Devi; U Hayat; J L Powell; J G Morris
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

10.  Necrotizing fasciitis due to Vibrio alginolyticus in an immunocompetent patient.

Authors:  Juan M Gomez; Roosevelt Fajardo; Jose F Patiño; Cesar A Arias
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.